Sermorelin mastery course
Unit 9 of 11

Safety and product quality

Sermorelin has a generally mild reported profile in the settings it was studied, but that reassurance is narrow.

What is reported, what is theoretical, and what is unknown

Sermorelin has a generally mild reported profile in the settings it was studied, but that reassurance is narrow. Some risks are theoretical, a review of the secretagogue class found few long-term, rigorously controlled studies, and none of the sources this course holds characterizes long-term safety for adults using sermorelin.

This unit sorts common effects from theoretical ones, frames IGF-1 as the guardrail, covers the product-quality problem of compounded supply, and walks through who should be most cautious.

Key terms

What is actually reported


What the approval record still supports


Endocrine effects to watch


IGF-1 as the safety ceiling


The compounded-product problem


Who should be most cautious